Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2020-09-08, Stock:ABBV, The news for the past five days is as follows:
2020-08-31: NEWS1: Why AbbVie (ABBV) is a Great Dividend Stock Right Now.NEWS2: Pharma Stock Roundup: AZN's Coronavirus Antibody Combo Study, & Other Updates.
2020-09-01: NEWS1: House Panel Investigating Drug Prices To Subpoena AbbVie.NEWS2: AbbVie 'Surprised, Disappointed' by House Panel Subpoena Plan.NEWS3: U.S. House Oversight Committee to subpoena AbbVie in drug-pricing probe.NEWS4: Forget Johnson & Johnson, AbbVie Is a Better Dividend Stock.
2020-09-02: NEWS1: 3 Ultra-High-Yield Medical Stocks That Aren't Done Growing Yet.
2020-09-03: NEWS1: AbbVie to Present at the Morgan Stanley Healthcare Conference.
2020-09-04: NEWS1: AbbVie Partners With I-Mab for Cancer Drug.NEWS2: AbbVie Inks $2.9 Billion Cancer Deal With China’s I-Mab.NEWS3: A Look Into AbbVie's Debt.NEWS4: AbbVie Partners With I-Mab for Cancer Treatment Candidate.NEWS5: I-Mab's stock soars after AbbVie collaboration, which could be worth nearly $2 billion.NEWS6: The Daily Biotech Pulse: AbbVie In-licenses I-Mab's Cancer Drug, Savara Pulls The Plug On Cystic Fibrosis Study.NEWS7: Like Dividends? I Bet You'll Love These 2 Stocks.NEWS8: AbbVie and I-Mab Enter Into Global Strategic Partnership for Differentiated Immuno-oncology Therapy.

Answer: Decrease